ASCO 2024 review: The benefits and barriers of biomarkers in oncology
Biomarkers: what do we mean? – The term “biomarkers” can be broadly clustered into four categories: molecular, histologic, radiographic and physiological. –...
Industries
Life Sciences
We bring clarity to complex challenges.
For more than 25 years, life science companies, law firms, and regulatory agencies around the globe have turned to CRA’s life sciences consultants when they need clarity and solutions to the industry’s most complex issues. Clients value our deep industry knowledge, rigorous analytic techniques, and decades of hands-on experience spanning thousands of successful engagements.
Engagements
- 01ITC Section 337 trial testimony on domestic industry for consumer wearable health monitoring technologyCRA’s Intellectual Property experts were retained by a global medical technology and consumer electronics company, to evaluate the economic prong of domestic...View engagement
- 02Lost profits, reasonable royalty damages analysis for respiratory-related medical devicesCRA’s Intellectual Property experts were retained by a multinational developer and manufacturer of respiratory-related medical devices to determine economic...View engagement
- 03Transforming the Medical Quality and Medical Affairs organizations through AI and data-driven decision makingA top global pharmaceutical company sought technological innovations to update their Medical Quality and Medical Affairs-related operating processes...View engagement
Contact a Life Sciences expert.
See all Life Sciences expertsLatest insights
Upcoming events
ESHRE 40th Annual Meeting
Hannah Armstrong is moderating a panel during a program entitled, “Policy Solutions to Improve Access to Fertility Treatment and Optimize Patient Care” and...
ACI 11th Annual Summit for Women Leaders in Life Sciences Law
Annabelle Fowler is a panelist on “Navigating Today’s Life Sciences M&A Landscape: Charting the Latest Trends and Challenges in Pharma and Biotech Dealmaking”...
Recent events
36th Annual ITA Workshop and Annual Meeting
CRA is a proud sponsor of the workshop. It is widely recognized as the leading International Arbitration conference held in the United States. The theme of the...
Proving But-for Entry Dates in Pharmaceutical Antitrust Litigation
A question arises in most pharmaceutical antitrust cases: when would generic entry have occurred absent the accused conduct? In this program, a panel of...